• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, May 3

The board of AstraZeneca Pharma India Ltd is meeting on May 9 to consider a stock split, the company has informed the stock exchange. The pharma MNC's scrip closed at just over Rs 4,570 on Wednesday. A month ago, it was trading at Rs 3,225 and touched Rs 3,868 a week ago.

Swedish parent Astra Pharma AB holds 90 per cent of the shares and Indian public holds 8.56 per cent or 4.27 lakh shares. Banks, FIs, NRIs, OCBs and others hold the rest. The company ended fiscal 2005 with a turnover of Rs 225 crore.

More Stories on : Stocks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
JRG Securities opens 403rd branch in Kochi

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line